Pura Vida Investments, LLC Taysha Gene Therapies, Inc. Transaction History

Pura Vida Investments, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$15.82 - $21.57 $535,064 - $729,540	-33,822 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$19.29 - $26.38 $652,426 - $892,224	33,822 New	33,822 $717,000
Q4 2020 Feb 16, 2021	SELL	$19.14 - $28.13 $191,400 - $281,300	-10,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$22.4 - $24.47 $224,000 - $244,700	10,000 New	10,000 $224,000

119

136M

25.9K

24K

Ticker TSHA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,359,500
Market Cap $97.2M
Description
Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for th...

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Pura Vida Investments, LLC with notifications on news.